<?xml version="1.0" encoding="UTF-8"?>
<p id="Par50">In addition, camel vaccines against MERS-CoV are a consideration. At present, at least two promising candidate camel vaccines are undergoing development, and field trial evaluation is in progress.
 <sup>
  <xref ref-type="bibr" rid="CR108">108</xref>,
  <xref ref-type="bibr" rid="CR146">146</xref>
 </sup> One study found that the RBD fragment covering spike residues 377–588 is a key neutralizing receptor-binding fragment and an ideal candidate for MERS vaccines.
 <sup>
  <xref ref-type="bibr" rid="CR147">147</xref>
 </sup> Another potential neutralizing epitope is a peptide fragment covering 736–761 residues of the S protein which blocks the membrane fusion and cellular entry of MERS-COV
 <sup>
  <xref ref-type="bibr" rid="CR114">114</xref>
 </sup> (Fig. 
 <xref rid="Fig5" ref-type="fig">5</xref>).
</p>
